MedPath
FDA Approval

TAVABOROLE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
May 12, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tavaborole(43.5 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Taro Pharmaceuticals Inc.

Taro Pharmaceuticals U.S.A., Inc.

206263295

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TAVABOROLE

Product Details

NDC Product Code
51672-1397
Application Number
ANDA212215
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
May 28, 2019
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
Code: K124A4EUQ3Class: ACTIBQuantity: 43.5 mg in 1 mL
EDETATE CALCIUM DISODIUMInactive
Code: 25IH6R4SGFClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
© Copyright 2025. All Rights Reserved by MedPath